Clonidine for Anxiety Treatment

Mechanism of Action and Approved Uses

Clonidine is an α2-adrenergic receptor agonist that suppresses sympathetic nervous system outflow throughout the brain, as noted by the American Academy of Sleep Medicine 1, 2
The FDA approves clonidine for attention-deficit/hyperactivity disorder (ADHD) and hypertension, but not specifically for anxiety disorders, according to the American Academy of Sleep Medicine 3
Clonidine works by enhancing noradrenergic neurotransmission in the prefrontal cortex, which strengthens top-down regulation of attention, thought, and working memory, as reported by the American Academy of Sleep Medicine 3

The American Academy of Sleep Medicine recommends clonidine for PTSD-associated nightmares (Level C recommendation - may be considered) 1, 2
Clonidine may be used for anxiety in children with intellectual disability/developmental disorders, although there is limited trial evidence, as noted by the American Academy of Sleep Medicine 3
The American Academy of Sleep Medicine suggests clonidine for short-term anxiolytic effects, although effects may not persist long-term, is not a recommended use 3

For PTSD-associated nightmares, the American Academy of Sleep Medicine recommends 0.2 to 0.6 mg in divided doses 1, 2
For ADHD, the American Academy of Sleep Medicine suggests a starting dose of 0.1 mg tablet at bedtime, which can be increased to twice-daily administration with careful uptitration; doses higher than 0.4 mg/day are not recommended, as reported by Pharmacology and Therapeutics 4
Evening administration is generally preferable due to the frequent occurrence of somnolence/fatigue as an adverse effect, according to Pharmacology and Therapeutics 4, 3

The most common adverse effects of clonidine include somnolence/sedation and fatigue (very common), as reported by Pharmacology and Therapeutics and the American Academy of Sleep Medicine 4, 1, 3
Hypotension and bradycardia (cardiovascular effects requiring monitoring) are potential adverse effects, according to Pharmacology and Therapeutics and the American Academy of Sleep Medicine 4, 3
Irritability, insomnia, and nightmares are also potential adverse effects, as noted by Pharmacology and Therapeutics and the American Academy of Sleep Medicine 4, 3
Dry mouth and dizziness are additional potential adverse effects, according to Pharmacology and Therapeutics and the American Academy of Sleep Medicine 4, 3

SSRIs (fluoxetine, sertraline) remain the first-line treatment of choice for anxiety disorders based on stronger evidence, as reported by the American Academy of Sleep Medicine 3
Clonidine should be considered when first-line treatments have failed or are contraindicated, or when specific anxiety subtypes are present (PTSD-related nightmares, anxiety with sleep disturbances), according to the American Academy of Sleep Medicine and Pharmacology and Therapeutics 3, 1, 2
Clonidine may also be considered when comorbid conditions like ADHD are present, as noted by Pharmacology and Therapeutics 4, 5

Clonidine's effect size for anxiety is generally smaller than first-line treatments, as reported by Pharmacology and Therapeutics 4, 5
Treatment effects are not usually observed until 2-4 weeks after initiation, according to Pharmacology and Therapeutics 4
Monitoring blood pressure and pulse regularly is recommended due to potential hypotensive effects, as noted by Pharmacology and Therapeutics and the American Academy of Sleep Medicine 4, 1, 3
The transdermal patch formulation may be considered for patients who might benefit from steady-state drug levels, according to Pharmacology and Therapeutics 4, 5